Over the last three months, we've seen significantly more insider buying, than insider selling, at Bristol-Myers Squibb.

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look ...

Shares of Bristol Myers Squibb Co. BMY shed 3.04% to $58.76 Tuesday, on what proved to be an all-around positive trading ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

In an amicus brief, several advocacy groups warned that letting the lawsuit proceed past a motion to dismiss could open the ...

Liaohai “Leo” Chen, a research scientist who oversaw a $20 million surgical robotics training facility while at the ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

The layoffs follow an announcement in early January that I-Mab will re-prioritize resources to focus on advancing a CLDN18.2 ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Mab’s pipeline pivot had a sting in the tail. Weeks after shifting its focus, the biotech said Wednesday that it has reduced ...